Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products
The Drug Enforcement Administration (DEA) is revoking the exempted status for certain nonnarcotic prescription products that are currently on DEA's Table of Exempted Prescription Products, but whose National Drug Codes (NDC) are inactive because they are no longer available and/or the company that applied for the exemption no longer exists. These products will be removed from DEA's Table of Exempted Prescription Products and will no longer be considered exempt prescription products under the Controlled Substances Act. This action does not impact exempted prescription products with active NDC numbers.
From Federal Register — all agencies (federalregister.gov). First seen Oct 10, 2026.
Details
- Published
- Oct 9, 2026Find in source ↗
- Agency
- Justice Department; Drug Enforcement AdministrationFind in source ↗
- Effective
- Nov 9, 2026Find in source ↗
- Action
- Final determination.Find in source ↗
- Dates statement
- This final determination is effective on November 9, 2026.Find in source ↗
- CFR parts affected
- 21 CFR 1308 Find in source ↗
- CFR titles
- Title 21: Food and Drugs Find in source ↗
- Dockets
- Docket No. DEA-1664Find in source ↗
- RINs
- 1117-ZA08Find in source ↗
- Citation
- 91 FR 64618Find in source ↗
- Official PDF
- govinfo.gov
History
No changes since RuleWatch first read this rule on Oct 10, 2026.
Sign in to keep notes on this rule, private or shared with your team.